September 2026
The predictive disease analytics market size reached USD 5.81 billion in 2026 and is expected to be worth around USD 23.08 billion by 2035 with a CAGR of 16.6%.
September 2026
The predictive analytics market size is calculated at USD 21.24 billion in 2026 and is projected to hit around USD 113.46 billion by 2035 with a CAGR of 20.56%.
September 2026
The healthcare predictive analytics market size stood at USD 27.66 billion in 2026, with major market companies including IBM Corporation, Oracle Corporation, Allscripts Healthcare, LLC, Cerner Corporation.
September 2026
The global aircraft data management market is growing with digital solutions that enhance aviation safety, efficiency, and compliance worldwide.
September 2026
The celiac disease treatment market was valued at USD 879.06 million in 2026, with leading companies including Takeda Pharmaceutical Company Limited, Amgen Inc.
September 2026
The rare diseases treatment market size was estimated at USD 266.68 billion in 2026and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
September 2026
The global parkinsons disease therapeutics market size is estimated at USD 7.49 billion in 2026 and is projected to hit around USD 14.28 billion by 2035 with a CAGR of 7.36%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The global advanced analytics market size reached USD 88.52 billion in 2026 and is projected to surpass around USD 390.93 billion by 2034 with a noteworthy CAGR of 20.55%.
September 2026
The global chronic disease management market size was estimated at USD 7.51 billion in 2026 and is expected to hit around USD 23.18 billion by 2035, growing at a CAGR of 13.37% from 2026 to 2035.
September 2026
The global agriculture analytics market size was evaluated at USD 8.53 billion in 2026 and is predicted to hit around USD 32.42 billion by 2035, growing at a CAGR of 16.00%.
September 2026
The financial analytics market size reached USD 11.46 billion in 2026, with leading financial analytics market companies including Symphony Teleca Corp., Oracle Corporation, IBM
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The prescriptive analytics market size is valued at USD 14.71 billion in 2026 and is projected to reach around USD 96.19 billion by 2035 with a CAGR of 23.28%.
September 2026
The global streaming analytics market size accounted for USD 53.22 billion in 2026, and it is projected to hit around USD 442.74 billion by 2035, at a CAGR of 26.61%.
September 2026
The geospatial imagery analytics market size is valued at USD 14.71 billion in 2026 and is estimated to hit around USD 19.62 billion by 2035 with a CAGR of 19.62%.
September 2026
The IT operations analytics market size accounted for USD 22.47 billion in 2025 and is expected to hit around USD 278.70 billion by 2035 with a CAGR of 28.63%.
September 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The global respiratory disease vaccine market size was calculated at USD 103.17 billion in 2026 and is projected to hit around USD 123.77 billion by 2035 with a CAGR of 2.04%.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
September 2026
The end stage renal disease market was valued at USD 174.43 billion in 2026, with end stage renal disease market leading companies including Nipro Corp., Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc.,Medtronic Plc.
September 2026
The analytics as a service (AaaS) market size was valued USD 18.67 billion in 2026 and is estimated to hit around USD 138.76 billion by 2035 with a CAGR of 25.06%.
September 2026
The global augmented analytics in BFSI market size is expected to attain around USD 23.85 billion by 2034 from USD 4.15 billion in 2026, with a CAGR of 24.43%.
September 2026
The global disease management apps market size is calculated at USD 10.20 billion in 2026 and is projected to hit around USD 27 billion by 2035 with a CAGR of 10.22%.
September 2026
The global artificial intelligence (AI) in inflammatory bowel disease market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2026 to 2034.
September 2026
The global graves disease (overactive thyroid) market size is estimated to hit around USD 3.69 billion by 2035 increasing from USD 2.37 billion in 2026, with a CAGR of 5.02%.
September 2026
The global risk analytics market size is estimated at USD 51.25 billion in 2026 and is expected to hit around USD 90.03 billion by 2034 with a CAGR of 7.34%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The healthcare analytics market size was calculated at USD 78.30 billion in 2026 and is projected to hit around USD 427.18 billion by 2035 with a CAGR of 20.81%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com